Novo Nordisk
Since 2003, Novo Nordisk has gained most in December (average +5.79%, higher in 83% of 23 years) and done worst in September (-1.53%). November has averaged +2.72%.
Grades describe the data. They are not buy or sell ratings.
Seasonality
Average return by calendar month, 2003 to 2026
Sell in May: November to April averaged +15.75%, May to October +4.61%; winter did better in 70% of 23 years. Compare markets
Month-by-month table
| Month | Average | Median | Up years | Last 10 years | Best | Worst | Years | Pattern |
|---|---|---|---|---|---|---|---|---|
| January | +0.77% | +1.67% | 57% | +1.70% | +15.31% | -50.42% | 23 | no clear pattern |
| February | +2.75% | +4.90% | 71% | -1.37% | +17.67% | -35.62% | 24 | weak |
| March | +2.67% | +2.12% | 63% | +1.13% | +18.09% | -25.89% | 24 | weak |
| April | +2.87% | +3.00% | 75% | +3.90% | +17.91% | -8.91% | 24 | moderate |
| May | +0.20% | +1.04% | 58% | +2.13% | +8.57% | -8.51% | 24 | no clear pattern |
| June | +2.45% | +2.63% | 58% | +2.46% | +12.32% | -3.88% | 24 | no clear pattern |
| July | +0.20% | -0.83% | 42% | -2.45% | +10.39% | -28.46% | 24 | no clear pattern |
| August | +2.27% | +1.68% | 54% | +5.64% | +19.58% | -16.71% | 24 | no clear pattern |
| September | -1.53% | -0.87% | 42% | -3.39% | +8.88% | -16.13% | 24 | moderate |
| October | +0.50% | +1.01% | 58% | +1.69% | +15.13% | -11.98% | 24 | no clear pattern |
| November | +2.72% | +2.23% | 78% | +2.39% | +9.22% | -3.85% | 23 | moderate |
| December | +5.79% | +2.60% | 83% | +0.69% | +102.10% | -17.58% | 23 | weak |
Ahead or behind the season
This year against the usual move by the same date
Usually higher in this period (68% of 22 years). 49 days in, 12 days left.
Past leaders mostly kept goingIn the 11 past years that were also ahead on this date, the rest of the period averaged +0.77% and ended higher in 73%.
Seasonal windows
Picked on older years, then checked on the last 10 years
Held in 7 of the last 10 years (2016 to 2025). Those years were not used to pick the window. Any window of this length went the same way in 57% of them.
Held in 7 of the last 10 years (2016 to 2025). Those years were not used to pick the window. Any window of this length went the same way in 55% of them.
We test every start date and every length from 10 to 90 days, so some windows look good by chance. To guard against that, we pick windows using the older years only and publish a window only if it also held in at least 6 of the last 10 years, which played no part in picking it. Each square is one year; green means the window worked. All open and upcoming windows
Technicals
50-day average below the 200-day
No active signal today. We watch 52-week highs and lows, RSI extremes and 50/200-day crossovers, and show what followed each in the past.
Year by year
Monthly moves for the last 16 years, most recent first
What drives Novo Nordisk
- GLP-1 obesity and diabetes drugs, competition with Eli Lilly and US pricing policy.
- Trial results and supply capacity announcements.
Questions
What is the best month for Novo Nordisk?
Since 2003, December has had the highest average move for Novo Nordisk at +5.79%, rising in 83% of 23 years. December has the highest share of positive years (83%).
What is the worst month for Novo Nordisk?
September has had the weakest average move at -1.53%, rising in 42% of 24 years.
How does Novo Nordisk usually do in November?
Novo Nordisk has averaged +2.72% in November (median +2.23%), rising in 78% of 23 years. We rate the pattern as moderate.
Questions, ideas or corrections?
Write to us. We read every email.
Not investment advice. Market Seasonality publishes historical statistics, news summaries and scenario analysis for information and education. Past patterns do not guarantee future results. Nothing here is a recommendation to buy, sell or hold any asset, and scenarios describe possible paths without predicting them. See the disclaimer and methodology.
